VOLUME 10 (2019)
View Archive »
About The Cover
The cover for issue 10 of Oncotarget features Figure 6, "Model of the role of LATS1/2 kinases in the pre–self-renewal (pre-SR) stage during sphere formation by CSCs," by Nozaki, et al.
|
|
Table of Contents
Priority Research Papers
|
| LATS1/2 kinases trigger selfrenewal of cancer stem cells in aggressive oral cancer |
|
https://doi.org/10.18632/oncotarget.26583
|
| 1014-1030 |
Research Papers
|
| Therapeutic potential of nimotuzumab PEGylatedmaytansine antibody drug conjugates against EGFR positive xenograft |
|
https://doi.org/10.18632/oncotarget.26613
|
| 1031-1044 |
|
| Glypican1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases |
|
https://doi.org/10.18632/oncotarget.26620
|
| 1045-1055 |
|
| Src kinase inhibition restores Ecadherin expression in dasatinibsensitive pancreatic cancer cells |
|
https://doi.org/10.18632/oncotarget.26621
|
| 1056-1069 |
|
| Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study |
|
https://doi.org/10.18632/oncotarget.26626
|
| 1070-1084 |
|
| Andrographolide induces DNA damage in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.26628
|
| 1085-1101 |
|
| Oxalate induces type II epithelial to mesenchymal transition EMT in inner medullary collecting duct cells IMCD <i>in vitro</i> and stimulate the expression of osteogenic and fibrotic markers in kidney medulla <i>in vivo</i> |
|
https://doi.org/10.18632/oncotarget.26634
|
| 1102-1118 |
|
| The correlation of p22<sup>phox</sup> and chemosensitivity in EGFRTKI resistant lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26637
|
| 1119-1131 |
|
| Repurposing old carbon monoxidereleasing molecules towards the antiangiogenic therapy of triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.26638
|
| 1132-1148 |
|
| Reliable evaluation of tumorinfiltrating lymphocytes in pancreatic cancer tissue biopsies |
|
https://doi.org/10.18632/oncotarget.26646
|
| 1149-1159 |
|
| Nterminal probrain natriuretic peptide reflects both left ventricular diastolic dysfunction and myelomarelated renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma |
|
https://doi.org/10.18632/oncotarget.26647
|
| 1160-1170 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
